
THC
18.8–22.3%
CBD
0.7%
Hash Lover is an indica from Freedom of Seeds crossing Hash Plant with Northern Lights, flowering in six to seven weeks with strong THC.
No effect, terpene, flavor or medical-use data specific to Hash Lover has been published yet, so we don't guess. For what indica strains usually do, see the effects guide.
THC in this profile
22.3% THC
Growing Information
Flowering Time
6–7 weeks
About Hash Lover
Freedom of Seeds crossed Hash Plant with Northern Lights to build this indica, pairing two of the more historically significant names in indica breeding into a single cross. THC testing runs from 18.8% up to 22.3%, a strong range that lines up with both parent lines' reputations for potency. Flowering takes just six to seven weeks, a notably fast timeline for an indica and shorter than either parent typically requires on its own, suggesting the cross favored speed alongside strength. No flavor, terpene, effect, or medical-use data has been published for this particular cut, so what's documented centers on the genetics, the potency, and that unusually quick finish. For growers who prioritize a fast turnaround without giving up THC content, the combination of numbers here is the clearest selling point available right now.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Hash Lover
Is Hash Lover an Indica, Sativa, or Hybrid?
Hash Lover is classified as a indica cannabis strain bred from a genetic cross of Hash Plant × Northern Lights.
What cannabinoid content is reported for Hash Lover?
Hash Lover: 22.3% THC and 0.7% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.
Similar Strains
Blue Angel
HYBRIDTHC 13.71%
Godberry
INDICATHC 12.7%
A Little Kushy Auto
INDICATHC 20%
3 Kingdoms
HYBRIDTHC 25%
Jelly Tots
INDICATHC 18%
Purple Mints
INDICATHC 24%
Afghan Hawaiian
INDICATHC 14%
Wedding Cake
INDICATHC 30.26%